Non-animal testing methods could save drugmakers time and money, officials say ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...

The U.S. Food and Drug Administration issued a draft guidance on Wednesday to help drug developers validate alternative methods that can be used in place of animal studies during early stages of drug ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

In a Policy Forum, Chad Nelson and colleagues highlight the efforts of the U.S. Food and Drug Administration (FDA) in advancing alternative methods to reduce animal testing for regulatory use. Animal ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

The UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) has announced funding of £4.5 million for 13 new ‘3Rs’ projects. The UK’s National Centre for the ...